Sarah Zuercher is a Bronx, New York based nurse practitioner. Active license number of Sarah Zuercher is F421174-1 for Women Health in New York. Her current practice location is 349 E 149th St Fl 3, Bronx. Patients can reach her at 212-965-4830. Sarah Zuercher is N.P. and her NPI number (Unique professional ID assigned by NPPES) is 1013323088. Sarah Zuercher has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Sarah Zuercher speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1013323088
NPI Enumeration Date:
10 Jul, 2014
NPI Last Update On:
21 Jul, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sarah Zuercher are as mentioned below.
License Number
Specialization
State
Status
F421174-1
Women Health
New York
Primary
641061-1
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Sarah Zuercher 349 E 149th St Fl 3, Bronx, New York
Zip:
10451-5603
Phone Number:
212-965-4830
Patients can reach Sarah Zuercher at 349 E 149th St Fl 3, Bronx, New York or can call to book an appointment on 212-965-4830.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.